Treatment of hepatocellular carcinoma: a systematic review.
about
How to Improve Therapeutic Ratio in Radiotherapy of HCCCurrent Treatment Approaches to HCC with a Special Consideration to TransplantationDevelopment and novel therapeutics in hepatocellular carcinoma: a reviewBrazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinomaImaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRILocal ablation for hepatocellular carcinoma in taiwanRecent advances in multidisciplinary management of hepatocellular carcinomaClinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and futureTherapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse ModelsActive Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles.MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27The role of hypoxia inducible factor-1 in hepatocellular carcinoma.Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction.Local iontophoretic administration of cytotoxic therapies to solid tumorsTrends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study.Preliminary results of ultrasound-guided laser ablation for unresectable metastases to retroperitoneal and hepatic portal lymph nodes.Combination of macrophage inflammatory protein 1 alpha with existing therapies to enhance the antitumor effects on murine hepatomaFocal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular CarcinomaAddition of n-butyl cyanoacrylate to classic transarterial chemoembolization may improve the radiological response in patients with hepatocellular carcinoma.ISG15 as a novel prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma.Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma.Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells.Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells.A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?Meta-analysis of the prognostic value of abnormally expressed lncRNAs in hepatocellular carcinoma.V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.A mixed analysis comparing nine minimally invasive surgeries for unresectable hepatocellular carcinoma patients.Role of estrogen in hepatocellular carcinoma: is inflammation the key?Study of natural IgG antibodies against vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging.Drug resistance-related miRNAs in hepatocellular cancer.Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression.Investigating genetic characteristics of hepatitis B virus-associated and -non-associated hepatocellular carcinoma.
P2860
Q26738862-953D3819-95EF-4862-90F3-4C1FE71D9A18Q26740375-CEA866E3-67D2-4491-B3CE-F054B8025B08Q26752854-649C5ACC-EFE7-490A-AC5F-BE1C4D9595EBQ26766707-64799EFD-E8A3-4FFC-91DC-AC8BE619E0D3Q26772233-3FD84FFA-6062-4C48-ABE5-14EC252F5101Q26829892-0CC5EEF0-A183-4123-B7D7-FB92B404CD14Q26863748-95EBBC38-A8A5-492C-9CB4-CA39FED6C588Q27013055-9E3B5A02-11A5-4816-875A-E70245161D1AQ27016138-CFF733C0-3FBF-4165-8D67-65CF533956CCQ28552977-BC33F775-22C6-42C6-8C6E-1342B3858AC5Q30964683-DD788F4C-4370-4618-BCB1-DC0058EA80D2Q33756226-49105363-9502-4F14-86BA-CC57350DC44FQ33914603-EF99FB03-FD26-487B-B47B-301643CC5DADQ34109952-6D60E6C4-DA97-4BEA-8B66-5E59B8E5AC4FQ34827556-B4D1B9D9-D5D0-475A-A1DC-A6D7AC927276Q34993924-E82F2478-B8C6-43AF-A4DA-FB2391A53665Q35669106-7DE507DA-1717-4A90-AF1B-DD37C74479E3Q35832285-11B73EDC-C6F8-4AC0-A665-09578FAB9B9EQ35861357-501B33A1-FE1F-4FDA-ACDC-70CEF2AE6FF2Q35983594-0A927093-1892-4748-9FBA-5AABCCC8EB46Q36045931-11A6DC1E-6676-496A-B3FB-70C4DE802B71Q36060393-CC415A10-0183-4852-A9FB-5E7B8DF2895DQ36066995-B76B2F27-C8D6-4C95-8C61-E41D5FF972A9Q36244298-7D098A44-6194-42A3-81E3-31B6FB7A0D5DQ36364693-C0B443D5-2773-430D-85A7-A62685A6371CQ36411445-886D2393-5699-4A73-B722-D1A79737B438Q36423170-57BAA8F9-7378-45C1-BC44-3F761A323FCDQ36674083-7E9A02AD-11F5-4BDF-978B-DE36384B6BB3Q36899877-2C3E8792-FBCA-4DC6-A599-5F88856E5FF6Q37031700-4B611F31-982A-4AC2-BD1D-E8486C9102D9Q37088265-CA7A8BBE-C9AD-4E94-9E70-25570E9D3635Q37197517-87BCF67D-FACB-49E6-9295-D1709560C89AQ37705990-2984FAF4-FD12-4434-8D3D-F5B0A6E8A0E6Q37706378-9D726952-0814-4243-8D0C-22803130C88FQ37710885-3BD41C5F-1DFC-4A40-9C07-516481DEBD1BQ37743524-72D8B5F1-969B-4216-99A5-6F2AB770B08DQ38083432-68F61D36-F00C-45C1-A5C3-21128EB5C076Q38185706-4BC5185C-ED3D-4443-BF82-E0917FBF0197Q38212153-A9AC37B3-BB88-4EC1-B482-B65B3FB61342Q38440403-79247CD3-8381-4268-9CFA-A1FE32AA041F
P2860
Treatment of hepatocellular carcinoma: a systematic review.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment of hepatocellular carcinoma: a systematic review.
@en
type
label
Treatment of hepatocellular carcinoma: a systematic review.
@en
prefLabel
Treatment of hepatocellular carcinoma: a systematic review.
@en
P2093
P2860
P356
P1433
P1476
Treatment of hepatocellular carcinoma: a systematic review.
@en
P2093
Katrin Hoffmann
Peter Schemmer
P2860
P304
P356
10.1159/000343828
P577
2012-11-01T00:00:00Z